A new look at triple-negative breast cancer

July 19, 2017

By Jan Jarvis

Breast Cancer
 
Triple-negative breast cancer (TNBC) is often aggressive, hard to treat and disproportionately affects carriers of the BRCA1 gene mutation and younger women of African origin.

Researchers at UNT Health Science Center have received a $1.9 million grant from the National Cancer Institute to help develop a new therapy that holds promise for the 38,000 to 55,000 women who are diagnosed with this disease each year.

Jamboor K Vishwanatha, PhD, and his colleagues – Pankaj Chaudhary, PhD, and Sumihiro Suzuki, PhD – will measure a protein called Annexin A2, which is shed from cancer cells and circulates in the blood.  This protein leads to the aggressiveness of triple-negative breast cancer and its metastasis to other organs, said Dr.Vishwanatha, Regents Professor and Vice President for Diversity and International Programs.

“Our research could potentially lead to a biomarker that can predict aggressive TNBC metastasis in African-American women, and possibly lead to development of new therapeutic options for women with this type of breast cancer,” Dr. Vishwanatha said.

About 15 percent to 20 percent of breast cancers are triple-negative. This means that three common receptors known to fuel most breast cancer growth – estrogen, progesterone, and the HER-2/neu gene – are not present in the tumor. As a result, common treatments like hormone therapy and drugs that target estrogen, progesterone, and HER-2 are ineffective.

Triple-negative breast cancer is prevalent in women who carry a mutated copy of the BRCA1 gene and in women of African descent. Those who are diagnosed with TNBC have a high frequency of metastasis to the lung, liver and brain, and survival is generally poor.

African-American women with TNBC tend to have worse clinical outcomes compared with women of European descent who have the disease. The disease is often more aggressive in African-American women.

The research could lead to better treatments for those who are disproportionately affected by this disease, said Dr. Chaudhary, Research Assistant Professor in the Institute of Molecular Medicine.

“We predict the results arising from the proposed studies will lay the foundation for future studies to determine if circulating levels of Annexin A2 need to be taken into consideration during study design in metastasis detection, prognosis, and therapy for African-American patients with TNBC,” Dr. Chaudhary said.

Dr. Suzuki, Associate Professor and Chair of Biostatistics and Epidemiology in the School of Public Health, will oversee data management, data cleaning and preparation, and data analyses.

To conduct this project, Dr. Vishwanatha is working with collaborators from across the country and around the world, including 14 institutions in Africa and Europe.

Liu Fc
PT on leading edge of Parkinson’s care

By Alex Branch   A UNT Health Science Center professor is preparing physical students to provide innovative care that can improve the quality of life for the nearly 1 million Americans expected to have Parkinson’s disease by 2020. Howe Liu, PT, PhD, Professor of Physical Therapy, pa...Read more

Sep 17, 2018

Abe Fc
A prestigious glaucoma prize, again, for UNTHSC eye researchers

By Jan Jarvis   In 1998, a team of researchers that included Abe Clark, PhD, won worldwide recognition for its discovery of the first gene that causes glaucoma. Two decades later, the same team has found a possible treatment for this blinding eye disease. “We’ve gone from discov...Read more

Sep 13, 2018

Prof Fc
UNT System honors scientist who conducts drug studies

By Jan Jarvis   One drug treats hospital-acquired bacterial pneumonia. Another treats complicated intra-abdominal infections. And a third treats skin infections. These are among the many drugs that Jerry Simecka, PhD, has evaluated as part of the discovery process since establishing th...Read more

Sep 12, 2018

Lena Fc
Fort Worth leaders praise new Early Learning Center at UNTHSC

By Alex Branch   Community leaders are hailing the opening of the Miles Foundation Early Learning Center, a partnership between UNT Health Science Center and Lena Pope, as a major step for high-quality, early childhood development in Fort Worth. Mayor Betsy Price, Tarrant County Judge ...Read more

Sep 11, 2018